Top Markets
Coin of the day
Pharnext S.A. Pharnext S.A.

Pharnext S.A.

ALPHA
Clasificación en acciones #42432
Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm... Based in France, Pharnext SA is a clinical-stage biopharmaceutical firm dedicated to creating treatments for a range of neurodegenerative disorders, encompassing both rare (orphan) and common forms. Its pipeline features SYNGILITY, which has advanced through Phase III trials for Charcot-Marie-Tooth disease type 1A (CMT1A). Additionally, PXT864 has concluded Phase II clinical studies for Alzheimer's disease, and is also being explored for its potential in Parkinson's disease and amyotrophic lateral sclerosis (ALS). Pharnext also innovates with PLEOTHERAPY, a proprietary platform that harnesses big genetic data and artificial intelligence. In a collaborative effort, the company holds an agreement with the University Hospital Institute Mediterranee Infection to assess existing pharmaceuticals for their potential application against the COVID-19 virus. The organization was established in 2007, with its main offices located in Issy-Les-Moulineaux, France.
Precio por acción
$0.00023723
Última sincronización: 2024-08-26
Capitalización bursátil
$1.41K
Cambio (1 día)
111.67%
Cambio (1 año)
0.00%
País
FR
Comercio Pharnext S.A. (ALPHA)

Categoría

Historial del precio de la acción de Pharnext S.A. (ALPHA)
Precio más alto de cierre: $0.00 el 2024-08-01

Precio más bajo de cierre: $2.68M el 2023-06-01
Historial del precio de la acción de Pharnext S.A. desde 2023 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2024 -100.00%
2023 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$527.87 36.13%
US
$873.57 37.02%
NL
$736.38 8.73%
CH
$263.09 20.45%
BE
$1.07K -5.56%
KR